Holen Sie sich die Stockscreener-App
15.28
0.59%
-0.09
Handel nachbörslich:
15.28
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLP?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$15.37
Offen:
$15.43
24-Stunden-Volumen:
231.35K
Relative Volume:
0.73
Marktkapitalisierung:
$308.74M
Einnahmen:
$80.54M
Nettoeinkommen (Verlust:
$-62.79M
KGV:
-4.8923
EPS:
-3.1233
Netto-Cashflow:
$20.76M
1W Leistung:
+8.37%
1M Leistung:
+4.95%
6M Leistung:
-11.63%
1J Leistung:
-53.76%
1-Tages-Spanne:
$15.18
$15.74
1-Wochen-Bereich:
$13.71
$15.74
52-Wochen-Spanne:
$11.09
$34.01
Simulations Plus Inc Stock (SLP) Company Profile
Firmenname
Simulations Plus Inc
Sektor
Branche
Telefon
661-723-7723
Adresse
800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA
Compare SLP vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLP
Simulations Plus Inc
|
15.28 | 310.56M | 80.54M | -62.79M | 20.76M | -3.1233 |
VEEV
Veeva Systems Inc
|
158.54 | 26.14B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
60.32 | 11.34B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.66 | 8.29B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
87.25 | 7.39B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
52.98 | 4.28B | 646.34M | -512.40M | 202.76M | -6.6871 |
Simulations Plus Inc Stock (SLP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-18 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-09-30 | Eingeleitet | TD Cowen | Hold |
| 2025-07-15 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-11-15 | Eingeleitet | Stephens | Overweight |
| 2024-07-29 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-07-16 | Eingeleitet | JMP Securities | Mkt Perform |
| 2024-06-28 | Eingeleitet | William Blair | Outperform |
| 2023-05-09 | Eingeleitet | BTIG Research | Buy |
| 2021-10-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2021-01-12 | Herabstufung | Craig Hallum | Buy → Hold |
| 2020-10-16 | Eingeleitet | Raymond James | Outperform |
| 2020-09-08 | Eingeleitet | Oppenheimer | Outperform |
| 2020-01-06 | Eingeleitet | Craig Hallum | Buy |
Alle ansehen
Simulations Plus Inc Aktie (SLP) Neueste Nachrichten
Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference - Business Wire
SLP Stock Price, Quote & Chart | SIMULATIONS PLUS INC (NASDAQ:SLP) - ChartMill
(SLP) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Simulations Plus president sells $16,530 in company stock - Investing.com UK
Simulations Plus president sells $16,530 in company stock By Investing.com - Investing.com India
Simulations Plus (SLP) executive exercises options and sells 1,000 shares under 10b5-1 plan - Stock Titan
TradingKey - TradingKey
[144] Simulations Plus, Inc. SEC Filing - Stock Titan
Nicholas Company Inc. Buys 78,854 Shares of Simulations Plus, Inc. $SLP - MarketBeat
NVIDIA Pushes AI Into Drug Development With Simulations Plus Collaboration - Yahoo Finance
Simulations Plus unveils method for QST model integration with microphysiological data in liver risk analysis - Traders Union
Simulations Plus collaborates with NVIDIA during AI drug modeling push - MSN
Simulations Plus, Inc. (SLP): Investor Outlook With A 47% Potential Upside - DirectorsTalk Interviews
Simulations Plus (SLP) Partners with NVIDIA for Advanced Drug De - GuruFocus
Simulations Plus teams with NVIDIA on drug modeling - Engineering.com
Simulations Plus (NASDAQ:SLP) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Simulations Plus Collaborates With Nvidia During AI Drug Modeling Push - Dailyhunt
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows - HPCwire
Simulations Plus partners with Nvidia on AI drug development By Investing.com - Investing.com India
Simulations Plus partners with Nvidia on AI drug development - Investing.com
Simulations Plus stock surges 28% on NVIDIA collaboration - Investing.com
Simulations Plus And NVIDIA Collaborate To Scale GPU-Accelerated, AI-Assisted Modeling Workflows - marketscreener.com
Simulations Plus stock surges 28% on NVIDIA collaboration By Investing.com - Investing.com Canada
Insider Sell Alert: DiBella John Anthony II Sells Shares of Simu - GuruFocus
[Form 4] Simulations Plus, Inc. Insider Trading Activity - Stock Titan
Simulations Plus (SLP) insiders sell 15,000 shares in planned trade - Stock Titan
Do options traders know something about Simulations Plus stock we don't? - MSN
(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Do Options Traders Know Something About Simulations Plus Stock We Don't? - TradingView
Simulations Plus (SLP) director receives 2,117-share equity grant as compensation - Stock Titan
Director Sharlene Evans receives 2,117 SLP shares in equity grant - Stock Titan
Director at Simulations Plus (SLP) receives 2,117-share stock grant - Stock Titan
Simulations Plus (SLP) director awarded 2,117 shares as equity compensation - Stock Titan
AI in Predictive Toxicology Research Report 2026 Featuring - GlobeNewswire
AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance UK
Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.
Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Latest SLP NewsSimulations Plus Announces Quarterly Cash Di... - Stock Titan
Simulations Plus Q2 2026 earnings preview - MSN
Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm
(SLP) Risk Channels and Responsive Allocation - Stock Traders Daily
Simulations Plus shares drop over 12% premarket as Q3 revenue forecast misses expectations - MSN
Finanzdaten der Simulations Plus Inc-Aktie (SLP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Simulations Plus Inc-Aktie (SLP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Fiedler-Kelly Jill | President, Services Solutions |
May 11 '26 |
Sale |
16.53 |
1,000 |
16,530 |
77,817 |
2.59%
3.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):